Discovery of (R)-(2-fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-hydroxypiperidin-1-yl)methanone (ML337), an mGlu3 selective and CNS penetrant negative allosteric modulator (NAM).

Wenthur CJ, Morrison R, Felts AS, Smith KA, Engers JL, Byers FW, Daniels JS, Emmitte KA, Conn PJ, Lindsley CW
J Med Chem. 2013 56 (12): 5208-12

PMID: 23718281 · PMCID: PMC3769689 · DOI:10.1021/jm400439t

A multidimensional, iterative parallel synthesis effort identified a series of highly selective mGlu3 NAMs with submicromolar potency and good CNS penetration. Of these, ML337 resulted (mGlu3 IC50 = 593 nM, mGlu2 IC50 >30 μM) with B:P ratios of 0.92 (mouse) to 0.3 (rat). DMPK profiling and shallow SAR led to the incorporation of deuterium atoms to address a metabolic soft spot, which subsequently lowered both in vitro and in vivo clearance by >50%.

MeSH Terms (11)

Allosteric Regulation Animals Brain Drug Discovery Humans Inhibitory Concentration 50 Mice Piperidines Rats Receptors, Metabotropic Glutamate Substrate Specificity

Connections (1)

This publication is referenced by other Labnodes entities: